Publications by authors named "Sercan Aksoy"

Claim this Profile
P
Prognostic significance of ductal carcinoma coexisting with invasive ductal carcinoma: Biological behavior, immune response and survival outcomes.
Neslihan Koray Fedai, Ilgin Koc, Gozde Kavgaci, Meral Uner, Aysegul Uner, Sercan Aksoy

Mol Clin Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib-induced autoimmune-like hepatitis: a case report.
Gozde Kavgaci, Taha Koray Sahin, Cenk Sokmensuer, Hatice Yasemin Balaban, Sercan Aksoy

J Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RE: Aprepitant use during chemotherapy and association with survival in women with early breast cancer.
Taha Koray Sahin, Deniz Can Guven, Sercan Aksoy

J Natl Cancer Inst· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program.
Mehmet Ali Nahit Sendur, Mutlu Hizal, Burcu Çakar, Oktay Halit Aktepe, Emrah Eraslan, Sercan Aksoy

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience.
Onur Baş, Bediz Kurt İnci, İmdat Eroğlu, Safa Can Efil, Seher Kaya, Sercan Aksoy

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6 Minute pegboard and ring test performance of patients with breast cancer compared to healthy controls: A cross-sectional study.
Hacer Oncu, Naciye Vardar-Yagli, Melda Saglam, Sercan Aksoy, Ebru Calik

J Back Musculoskelet Rehabil· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology Group.
Salih Tunbekici, Gokhan Sahin, Sercan Ön, Ahmet Oruc, Melek Karakurt Eryılmaz, Sercan Aksoy, Fatma Paksoy Turkoz

Int J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and survival outcomes in metastatic head and neck adenoid cystic carcinoma.
Hatice Bölek, Mehmet Kayaalp, Taha Koray Şahin, Osman Talha Doğan, Seher Yüksel, Sercan Aksoy

BMC Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
Seda Kahraman, Enes Erul, Ozge Gumusay, Deniz Can Guven, Sercan Aksoy, Asude Aksoy, Nail Paksoy

Clin Breast Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aromatase Inhibitor-Related Lower Limb Tendinopathies: Ultrasound is on the Agenda.
Berkay Yalçınkaya, Ahmet Furkan Çolak, Sercan Aksoy, Murat Kara, Levent Özçakar

Eur J Breast Health· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Drug interactions and special considerations in breast cancer patients treated with CDK4/6 inhibitors: A comprehensive review.
Taha Koray Sahin, Gozde Kavgaci, Deniz Can Guven, Sercan Aksoy

Cancer Treat Rev· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of serum albumin-creatinine ratio as a biomarker in patients treated with immune checkpoint inhibitors.
Onur Bas, Mert Tokatlı, Naciye Guduk, Dilara Erdoğan, Nur Evşan Boyraz, Sercan Aksoy

Immunotherapy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor: Comment on "Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy".
Kadriye Başkurt, Berkan Karabuğa, Nurlan Mammadzada, Osman Sütcüoğlu, Sercan Aksoy

Nutr Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study.
Serhat Sekmek, Aysel Oguz, Melek Karakurt Eryilmaz, Murat Araz, Sedat Biter, Sercan Aksoy

J Clin Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel.
Hakan Taban, Mustafa Erman, Deniz Can Guven, Burak Yasin Aktas, Feride Yilmaz, Sercan Aksoy

Medicina (Kaunas)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors.
Taha Koray Sahin, Deniz Can Guven, Yakup Ozbay, Firat Atak, Sevtap Arslan, Sercan Aksoy

Immunotherapy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral selective estrogen receptor degraders (SERDs) in hormone receptor-positive HER2-negative metastatic breast cancer after progression with CDK4/6 inhibitors.
Taha Koray Sahin, Sercan Aksoy, Deniz Can Guven

Expert Rev Anticancer Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitors.
Onur Baş, Mert Tokatlı, Mehmet Şavklıyıldız, Yiğit Yazarkan, Naciye Guduk, Sercan Aksoy

Expert Rev Anticancer Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors.
Taha Koray Sahin, Deniz Can Guven, Mert Durukan, Gozde Kavgaci, Yunus Kaygusuz, Sercan Aksoy

Expert Rev Mol Diagn· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer.
Taha Koray Sahin, Alessandro Rizzo, Deniz Can Guven, Sercan Aksoy

Cancer Treat Rev· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Management of Patients Admitted to the Supportive Care Clinic and Predisposing Factors of Unplanned Hospital Readmission: Single-Center Experience.
Onur Baş, Mert Tokatlı, Naciye Güdük, Dilara Erdoğan, Nur Evşan Boyraz, Sercan Aksoy

J Clin Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer.
Onur Baş, Naciye Güdük, Mert Tokatlı, Deniz Can Güven, Necla Özer, Sercan Aksoy

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The perspectives and knowledge of patients with cancer on mpox and mpox vaccination: a cross-sectional study.
Taha Koray Sahin, Yunus Kaygusuz, Mehmet Cihan İcli, Sercan Aksoy, Deniz Can Guven

Curr Med Res Opin· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between HALP score and survival in patients treated with immune checkpoint inhibitors.
Taha Koray Sahin, Deniz Can Guven, Mert Durukan, Onur Baş, Yunus Kaygusuz, Sercan Aksoy

Expert Rev Anticancer Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-operative serum CEA predicts prognosis in HR-positive/HER2-negative early breast cancer.
Gozde Kavgaci, Taha Koray Sahin, Tugcenur Muderrisoglu, Serez Ileri, Deniz Can Guven, Sercan Aksoy

Expert Rev Anticancer Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis